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available, and many other factors. The list in Table 3 is
by no means exhaustive and has been designed to facilitate
the decision as to whether a given instrument is practicable
under the conditions prevailing in the laboratory concerned.
These criteria cannot be assessed as objectively as those
given previously.
Conclusions
Consideration of the above criteria should make it possible to
arrive at an objective decision at all times. However, it is
essential that the following conditions are satisfied: (1) that
suitable, quantifiable test parameters exist for these criteria;
(2) that requirements are laid down for these test parameters,
e.g. optimum values; and (3) that suitable data and information
are available to cover the range of instruments from which
selection is to be made. The conditions are far from satisfied
and for this reason the IFCC Expert Panel on Instrumentation
has a most important task the evaluation and drafting of
appropriate recommendations and standards.
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THE performance and final choice of an analytical instrument
are usually judged on two criteria, external and internal. The
former are dependent on the experience of others, especially
if the evaluation was carried out under conditions comparable
to those in the purchaser’s own laboratory. The latter relate
to the purchaser’s own assessment.
The clinical requirements
There are, as yet, no "objective" rules for establishing clinical
performance criteria for a particular biomedical analysis.
Instead, it is frequently necessary to use allowable limits of
error which are based upon present knowledge of the clinical
requirements for systematic and random errors, while awaiting
more accurate data arising from conferences. That held at
Aspen in 1976 by the College of American Pathologists [1]
forms a suitable guideline for these.
External evaluations
These may take the form of published papers, reports given
at regional, national and international meetings, or documents
produced on behalf of or by various national, professional and
governmental organisations. This information may be available
from the manufacturer, but a list of evaluations has been
published in the British Association of Clinical Biochemists’
Newsletter, [2] and a revised list in a WHO Newsletter. It is
the intention of the IFCC Expert Panel on Instrumentation
to publish a revised list on a regular basis.
The Instrumentation Commission of the Clinical Biology
Society of France produced a multi-centre evaluation
protocol with which they assessed various enzyme rate
analysers. This was based upon the National Comittee of
Clinical Laboratory Standards Proposed Standard Evaluation
Protocol 1,3 and work by Broughton et al [4 ]. A working
group of the German Society for Clinical Chemistry has taken
this document and on behalf of the Expert Panel on Instru-
mentation of the IFCC, intend to prepare an evaluation
procedure which should either be, or provide the basis for, an
international standard. The final report prepared from data
supplied by more than one laboratory will be less affected by
the work patterns of each testing laboratory. It will therefore
provide a strong basis for comparison.
Multi-centre trial
The proposed procedure will take the form of a multi-centre
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trial and include coverage of a range of parameters which are
discussed in the following paragraphs.
Technical evaluation
This should take place before the analytical assessment and
include electrical and mechanical safety, mechanical reliability
of moving parts, physical characteristics, for example, of
temperature control, stability against voltage variation and a
review and audit of manufacturers claims concerning tech-
nical specifications.
Ana!v tical evaluation
Familiarisation protocol
The design of this protocol will allow the laboratories
concerned to become familiar with the operation of the
instrument and to determine whether compatible data are
being produced by all laboratories taking part in the trial.
Full evaluation protocol
This section of the analytical evaluation is commenced only
if results from the technical and familiarisation evaluations
are acceptable. It includes coverage of the following:
Method dependent functions. The performance of the
instrument should be assessed by carrying out analytical
procedures which challenge the various units, such as the
pipetting mechanism, mixing device and spectrometer. The
protocol includes provision for the testing of precision,
accuracy, interferences, stability of reagents and drift, and
provides sufficient data for the statistical analysis.
Throughput. An estimate of the time taken to analyse a
sample and the maximum possible throughput per hour and
day, taking into account standardisation and quality control
procedures. Estimates would be made both when the instru-
ment is fully operational and also when the instrument has to
be started up.
Precision. A study of intra- and inter-batch replication of
results should be made on samples with critical concentra-
tion(s) of analyte(s) and similar replicates from prepared
coloured solutions. The design will provide information on
the stability of reagents .and drift.
Accuracy. The accuracy of results obtained should be com-
pared against a reference or recommended method using
materials with reference or consensus values. The effect of
interferences on accuracy can be determined by testing related
compounds and using haemolysed, icteric, or lipaemic sera.
Criteria of acceptability. The criteria of acceptability with
regard to inaccuracy and imprecision should be agreed before
any trial is undertaken.
Method independent, functions. The protocol should be
adapted to suit the system under assessment and may cover
such functional modules as the signal measuring units,
temperature control, volume dispensing devices and the
effects of evaporation and contamination.
Flexibility. The flexibility of the system should be judged
by considering such points as the possibility of using other
chemical methods to measure the analytes, and other sources
of reagents.
Cost effectiveness (cost per test). The cost of analysing 1, 20
or 50 samples, and of running the instrument at its maximum
capacity should be determined.
Operator and service manuals. The quality of the instruction
manual is a good guide to the quality of the instrument and
to the service support available.
Maintenance service. A critical appraisal of the service which
can be provided either by the manufacturer or the distributor
is necessary.
Review and audit of manufacturer’s claims. This should be
undertaken using the guidelines such as those produced by
the Expert Panel on Instrumentation [5,6] and by the
American Association of Clinical Chemists for reagent kits
[71.
Internal evaluations
When an assessment of the available instruments has been
made by comparing the analytical and technical specifications
with the results of any available external evaluations, an
internal evaluation should be undertaken on the instrument
of choice to determine whether it meets the laboratory’s
over-all requirements.
The scheme should include analysis of patients’ sera with
concentrations of the analytes covering the analytical range,
together with a measurement of intra-and interbatch
precision, and a review of the information provided by the
manufacturer. If no report of a reliable external evaluation is
available, as much as is practical of the previously suggested
external evaluation procedure should be carried out.
Summary
The schedules outlined above should provide the basis for the
assessment of other instruments as well as chemical analysers.
It is difficult to recommend specific procedural details in a
testing approach which is intended for broad application, and
when evaluating a specific instrument. The user will need to
adapt the guidelines as necessary. The overall practicability
of an instrument for any laboratory may be determined from
the following: results of evaluations, required sample volume,
technical time required, sample throughput, time for
maintenance and cleaning procedures, the quality of the
information provided in the service and operator manual, the
after sales service backup, and cost effectiveness. It must be
emphasized that if a laboratory’s requirements are carefully
defined beforehand, the final selection of the correct instru-
ment will be greatly expedited and simplified.
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